Literature DB >> 7789593

A clinical, mammographic, sonographic and histologic evaluation of breast cancer.

H Meden1, K P Neues, S Röben-Kämpken, W Kuhn.   

Abstract

OBJECTIVE: To evaluate histologic tumor size in comparison with preoperative determination of tumor diameter by palpation, mammography and sonography.
METHODS: In a retrospective analysis we compared the histologic, clinical, mammographic and sonographic findings obtained from 160 patients with breast carcinoma.
RESULTS: The histologically determined tumors showed an average diameter of 25.7 mm. By comparison, the average tumor diameter determined by mammography, sonography and palpation was 23.8, 26.1 and 30.6 mm, respectively. Mammography was capable of detecting 94.5% of breast carcinomas, breast sonography 91% and palpation 87%. The combinations of mammography and sonography or mammography and palpation detected 99% of carcinomas, and sonography and palpation 95% of carcinomas.
CONCLUSION: As supplementary methods to preoperative clinical examination, mammography and breast sonography are mutually complementary, high-resolution imaging techniques of utmost importance in the preoperative diagnosis and surgical treatment of breast cancer patients.

Entities:  

Mesh:

Year:  1995        PMID: 7789593     DOI: 10.1016/0020-7292(94)02278-7

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  2 in total

1.  Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer.

Authors:  R J Burcombe; A Makris; P I Richman; F M Daley; S Noble; M Pittam; D Wright; S A Allen; J Dove; G D Wilson
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

2.  Differences between the clinical and histopathological tumor stages in breast cancer diagnosed using vacuum-assisted breast biopsy.

Authors:  Hai-Lin Park; Ji-Sun Hong; So Yong Chang; Jung Yin Huh; Ji Eun Shin; Ji-Young Kim; Jeong Yun Shim; Songmi Noh
Journal:  Oncol Lett       Date:  2015-02-09       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.